Study of chronic myeloid leukemia treatment in Kuwait
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at the health and treatment patterns of people with chronic myeloid leukemia in Kuwait to better understand their needs and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia (CML), a type of blood cancer.
- You have received at least one type of targeted therapy called a tyrosine kinase inhibitor (TKI).
- You have medical records available for at least 6 months before your diagnosis or start of treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks the experiences and health outcomes of people with chronic myeloid leukemia (CML) who are taking approved first or second line tyrosine kinase inhibitor (TKI) medicines. It helps doctors learn how these treatments work in everyday care.
This study uses a very sensitive blood test (digital PCR) to look for specific genetic mutations (changes) in the BCR::ABL1 gene in people with CML. The goal is to understand why some treatments stop working, which can help doctors choose the next best medication for you.
This study looks at how chronic myeloid leukemia (CML) affects your daily life and how care is organized in Lombardy hospitals. Researchers want to learn from your experiences to improve care for everyone with CML.
This study is watching how well asciminib (Scemblix) works in real life for people with chronic-phase CML in Saudi Arabia. If you've already tried two or more targeted therapies (TKIs) and recently started asciminib, this study may help doctors understand more about its effectiveness and side effects.
This trial looks at how gut bacteria affect the way chronic myeloid leukemia (CML) patients respond to tyrosine kinase inhibitor (TKI) medications. It may help doctors understand why some people have better outcomes than others.
This study looks at people who have chronic myeloid leukemia and later develop kidney disease. It aims to see how the leukemia may affect the kidneys, and it might help find better ways to manage kidney health in CML patients.
Hear when a new Leukemia, Myeloid, Chronic-Phase trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.